TRACIK FERENC enters NEUROSENSE THERAPEUTICS LTD. with 617.63K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001213900-26-030601
Officer· Chief Medical Officer
Since Mar 2026
617.63K
Baseline shares
100% direct
617.63K
Direct ownership
2 positions
174.67K
Derivative underlying
2 instruments
2
Security positions
All direct
Non-Derivative Holdings2
Ordinary Shares
DirectShares owned189.62K
Ordinary Shares
DirectShares owned428.01K
Total
617.63K direct617.63K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 189.62K | Direct |
| Ordinary Shares | 428.01K | Direct |
| Total | 617.63K | 617.63K direct |
Derivative Holdings2
Warrants to purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
66.67K
Shares owned
N/A
Exercise price
0.75
Expiration
—
Exercise window
—
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
108K
Shares owned
N/A
Exercise price
3.51
Expiration
—
Exercise window
—
Total
Underlying
174.67K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants to purchase Ordinary Shares Direct | Ordinary Shares | 0.75 | — | — | 66.67K | N/A |
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 3.51 | — | — | 108K | N/A |
| Total | 174.67K | 0.00 | ||||